KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Total Current Liabilities (2016 - 2025)

Gsk (GSK) has 4 years of Total Current Liabilities data on record, last reported at $26.1 billion in Q4 2023.

  • For Q4 2023, Total Current Liabilities changed N/A year-over-year to $26.1 billion; the TTM value through Dec 2023 reached $26.1 billion, changed N/A, while the annual FY2023 figure was $26.2 billion, N/A changed from the prior year.
  • Total Current Liabilities reached $26.1 billion in Q4 2023 per GSK's latest filing, down from $28.9 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $26.1 billion in Q4 2023 and bottomed at $26.1 billion in Q4 2023.